MCM
BRLI

Manchester Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Manchester Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,725
Closed -$88K – 1076
2014
Q4 		$88K Sell
2,725
-1,950
-42% -$56.4K 0.01% 583
2014
Q3 		$131K Buy
4,675
+275
+6% +$8.38K 0.02% 489
2014
Q2 		$133K Hold
4,400
– – 0.02% 493
2014
Q1 		$122K Buy
4,400
+2,200
+100% +$57.6K 0.02% 480
2013
Q4 		$56K Buy
+2,200
New +$67.8K 0.01% 578

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manchester Capital Management's BRLI Position: Q1 2015 in Review

Manchester Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2015, closing a stake of 2,725 shares — an estimated $88K sold.

Manchester Capital Management first reported a position in BRLI in Q4 2013 and held it in 5 quarters. The position peaked at $133K in Q2 2014. 168 funds tracked by Wall St. Rank hold BRLI as of Q1 2015.

  • Manchester Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2015 after selling out during the quarter.
  • Manchester Capital Management sold 2,725 BIO-REFERENCE LABS INC-NEW- shares in Q1 2015, an estimated $88K.
  • Manchester Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 5 quarters.
  • Manchester Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $133K in Q2 2014.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2015.

Based on Manchester Capital Management's 13F filing for Q1 2015, filed 7 May 2015.